Scilex Holding Company, a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., to Become Publicly Traded Through a Merger With Vickers Vantage Corp. I
Combined company expected to have a pro forma equity value post-money of approximately $1.64 billion,…